132 related articles for article (PubMed ID: 2362192)
21. Evaluation and clinical relevance of patient immune responses to intravenous therapy with murine monoclonal antibodies conjugated to adriamycin.
Avner B; Swindell L; Sharp E; Liao SK; Ogden JR; Avner BP; Oldham RK
Mol Biother; 1991 Mar; 3(1):14-21. PubMed ID: 2069755
[TBL] [Abstract][Full Text] [Related]
22. Purification and composition of the human tumor-associated glycoprotein (TAG-72) defined by monoclonal antibodies CC49 and B72.3.
Sheer DG; Schlom J; Cooper HL
Cancer Res; 1988 Dec; 48(23):6811-8. PubMed ID: 3180090
[TBL] [Abstract][Full Text] [Related]
23. Phenotypic characterization of lung cancers in fine needle aspiration biopsies using monoclonal antibody B72.3.
Johnston WW; Szpak CA; Thor A; Schlom J
Cancer Res; 1986 Dec; 46(12 Pt 1):6462-70. PubMed ID: 3022920
[TBL] [Abstract][Full Text] [Related]
24. Improved detection of the early stages of colon cancer by determining both free circulating and immune complex-bound antigens reactive with monoclonal antibody.
Chester SJ; Lim YP; Vezeridis MP; Hixson DC
Cancer Res; 1994 Aug; 54(15):3974-8. PubMed ID: 8033125
[TBL] [Abstract][Full Text] [Related]
25. In vitro complex formation and biodistribution of mouse antitumor monoclonal antibody in cancer patients.
Sakahara H; Reynolds JC; Carrasquillo JA; Lora ME; Maloney PJ; Lotze MT; Larson SM; Neumann RD
J Nucl Med; 1989 Aug; 30(8):1311-7. PubMed ID: 2754487
[TBL] [Abstract][Full Text] [Related]
26. Comparison of serum assays for TAG-72, CA19-9 and CEA in gastrointestinal carcinoma patients.
Ohuchi N; Takahashi K; Matoba N; Sato T; Taira Y; Sakai N; Masuda M; Mori S
Jpn J Clin Oncol; 1989 Sep; 19(3):242-8. PubMed ID: 2810823
[TBL] [Abstract][Full Text] [Related]
27. A phase I trial of humanized monoclonal antibody A33 in patients with colorectal carcinoma: biodistribution, pharmacokinetics, and quantitative tumor uptake.
Scott AM; Lee FT; Jones R; Hopkins W; MacGregor D; Cebon JS; Hannah A; Chong G; U P; Papenfuss A; Rigopoulos A; Sturrock S; Murphy R; Wirth V; Murone C; Smyth FE; Knight S; Welt S; Ritter G; Richards E; Nice EC; Burgess AW; Old LJ
Clin Cancer Res; 2005 Jul; 11(13):4810-7. PubMed ID: 16000578
[TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetics of iodine-125 CC49 monoclonal antibody in patients with colon cancer.
Cook CH; Hinkle GH; Thurston MO; Martin EW
Cancer Biother Radiopharm; 1996 Dec; 11(6):415-22. PubMed ID: 10851502
[TBL] [Abstract][Full Text] [Related]
29. Quantitative analyses of selective radiolabeled monoclonal antibody localization in metastatic lesions of colorectal cancer patients.
Colcher D; Esteban JM; Carrasquillo JA; Sugarbaker P; Reynolds JC; Bryant G; Larson SM; Schlom J
Cancer Res; 1987 Feb; 47(4):1185-9. PubMed ID: 3802099
[TBL] [Abstract][Full Text] [Related]
30. Direct localization comparison of murine and chimeric B72.3 antibodies in patients with colon cancer.
Meredith RF; Khazaeli MB; Grizzle WE; Orr RA; Plott G; Urist MM; Liu T; Russell CD; Wheeler RH; Schlom J
Hum Antibodies Hybridomas; 1993 Oct; 4(4):190-7. PubMed ID: 8257773
[TBL] [Abstract][Full Text] [Related]
31. A simple and sensitive assay for determination of human anti-idiotypic anti-B72.3 antibodies, which is not affected by the presence of tumour-associated glycoprotein 72.
Reinsberg J; Schmolling J; Ackermann D
Eur J Clin Chem Clin Biochem; 1996 Mar; 34(3):237-44. PubMed ID: 8721411
[TBL] [Abstract][Full Text] [Related]
32. Potential artifact for the increase of tumor associated antigens in serum samples from patients injected with monoclonal antibodies.
Ferroni P; Milenic DE; Roselli M; Carrasquillo JA; Raubitschek A; Schlom J; Colcher D
Int J Rad Appl Instrum B; 1991; 18(4):383-7. PubMed ID: 1864726
[TBL] [Abstract][Full Text] [Related]
33. Complementation of intracavitary and intravenous administration of a monoclonal antibody (B72.3) in patients with carcinoma.
Colcher D; Esteban J; Carrasquillo JA; Sugarbaker P; Reynolds JC; Bryant G; Larson SM; Schlom J
Cancer Res; 1987 Aug; 47(15):4218-24. PubMed ID: 3607761
[TBL] [Abstract][Full Text] [Related]
34. Comparative dual label study of first and second generation antitumor-associated glycoprotein-72 monoclonal antibodies in colorectal cancer patients.
Gallinger S; Reilly RM; Kirsh JC; Odze RD; Schmocker BJ; Hay K; Polihronis J; Damani MT; Shpitz B; Stern HS
Cancer Res; 1993 Jan; 53(2):271-8. PubMed ID: 8417820
[TBL] [Abstract][Full Text] [Related]
35. Frequent anti-V-region immune response to mouse B72.3 monoclonal antibody.
Khazaeli MB; Saleh MN; Liu T; Kaladas PM; Gilman SC; LoBuglio AF
J Clin Immunol; 1992 Mar; 12(2):116-21. PubMed ID: 1373150
[TBL] [Abstract][Full Text] [Related]
36. Assay for the detection of anti-idiotypic antibodies to monoclonal antibody B72.3.
Ferroni P; Milenic DE; Schlom J; Colcher D
J Clin Lab Anal; 1990; 4(6):465-73. PubMed ID: 2283566
[TBL] [Abstract][Full Text] [Related]
37. Clinical comparison of radiolocalization of two monoclonal antibodies (mAbs) against the TAG-72 antigen.
Divgi CR; Scott AM; McDermott K; Fallone PS; Hilton S; Siler K; Carmichael N; Daghighian F; Finn RD; Cohen AM
Nucl Med Biol; 1994 Jan; 21(1):9-15. PubMed ID: 9234259
[TBL] [Abstract][Full Text] [Related]
38. Anti-TAG-72 antibody B72.3--immunological and clinical effects in ovarian carcinoma.
Schmolling J; Reinsberg J; Wagner U; Krebs D
Hybridoma; 1997 Feb; 16(1):53-8. PubMed ID: 9085129
[TBL] [Abstract][Full Text] [Related]
39. Imaging of colorectal carcinoma with 131I B72.3 monoclonal antibody.
Carrasquillo JA
Targeted Diagn Ther; 1992; 6():45-55. PubMed ID: 1576349
[No Abstract] [Full Text] [Related]
40. Antiidiotypic response against murine monoclonal antibodies reactive with tumor-associated antigen TAG-72.
Blanco I; Kawatsu R; Harrison K; Leichner P; Augustine S; Baranowska-Kortylewicz J; Tempero M; Colcher D
J Clin Immunol; 1997 Jan; 17(1):96-106. PubMed ID: 9049790
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
